Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Welcome to the SIGA Business Update Call. Before we turn the call ...

For more than a decade, I have worked as a physician and public-health expert responding to infectious diseases around the ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

A column by Winona LaDuke, an Ojibwe writer and economist on Minnesota’s White Earth Reservation. She also is co-curator of ...

Turn on the news. Another war. Another environmental disaster. Another political scandal. The digital age delivers an ...

The European Union has responded with retaliatory tariffs of its own, with a special focus on products from red states.

A national medical ethics group is pressuring regulators to shutter Oregon Health & Science University’s primate research ...

In fact, although never before so brutally and blatantly, the United States has bribed and bullied the WHO from the earliest ...

16."The Dancing Plague in Strasbourg of 1518. It's a wild historical story. People just started breaking out in dance and ...

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

We increasingly hear pleas from those who are suffering agonizing pain not only about pain management but also about ways to end their lives.